triazolam has been researched along with Experimental Lung Inflammation in 1 studies
Triazolam: A short-acting benzodiazepine used in the treatment of insomnia. Some countries temporarily withdrew triazolam from the market because of concerns about adverse reactions, mostly psychological, associated with higher dose ranges. Its use at lower doses with appropriate care and labeling has been reaffirmed by the FDA and most other countries.
Experimental Lung Inflammation: Inflammation of any part, segment or lobe, of the lung parenchyma.
| Excerpt | Relevance | Reference |
|---|---|---|
| "A case of repetitive hallucinations during treatment with a therapeutic dosage of triazolam (0." | 7.69 | Hallucinations after a therapeutic dose of benzodiazepine hypnotics with co-administration of erythromycin. ( Kaneko, S; Kondo, T; Mihara, K; Morita, S; Otani, K; Tokinaga, N, 1996) |
| "A case of repetitive hallucinations during treatment with a therapeutic dosage of triazolam (0." | 3.69 | Hallucinations after a therapeutic dose of benzodiazepine hypnotics with co-administration of erythromycin. ( Kaneko, S; Kondo, T; Mihara, K; Morita, S; Otani, K; Tokinaga, N, 1996) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Tokinaga, N | 1 |
| Kondo, T | 1 |
| Kaneko, S | 1 |
| Otani, K | 1 |
| Mihara, K | 1 |
| Morita, S | 1 |
1 other study available for triazolam and Experimental Lung Inflammation
| Article | Year |
|---|---|
Hallucinations after a therapeutic dose of benzodiazepine hypnotics with co-administration of erythromycin.
Topics: Anti-Anxiety Agents; Drug Therapy, Combination; Erythromycin; Hallucinations; Humans; Kidney Failure | 1996 |